These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9083718)

  • 1. The evaluation of suspected immune deficiency by the primary care physician.
    Infante AJ; Kamani NR
    Compr Ther; 1997 Feb; 23(2):89-94. PubMed ID: 9083718
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment.
    Champi C
    J Pediatr Health Care; 2002; 16(1):16-21. PubMed ID: 11802116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pediatric testing and primary immunodeficiencies].
    Aiuti A
    Minerva Pediatr; 2009 Dec; 61(6):785-7. PubMed ID: 19935552
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation.
    Nahirniak S; Hume HA
    Transfus Med Rev; 2010 Jan; 24 Suppl 1():S1-6. PubMed ID: 19962578
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secondary immunodeficiencies].
    Giraldo Castellano P
    Sangre (Barc); 1999 Apr; 44(2):155-61. PubMed ID: 10382325
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Martín-Santiago A; Hervás JA; Hervás D; Rosell A; Caimari M; de Carlos JC; Matamoros N
    Pediatr Dermatol; 2013; 30(6):e221-2. PubMed ID: 23534934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches in the therapy of immunodeficiency.
    Fleisher TA; Blaese RM
    Allergy Proc; 1993; 14(6):409-11. PubMed ID: 8157164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gamma globulins in clinical practice].
    Panizon F
    Pediatr Med Chir; 1993; 15(4):333-5. PubMed ID: 7505432
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence of primary immunodeficiency syndromes in Israel.
    Golan H; Dalal I; Garty BZ; Schlesinger M; Levy J; Handzel Z; Wolach B; Rottem M; Goldberg A; Tamir R; Koren A; Levy Y; Katz Y; Passwell J; Etzioni A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):868-71. PubMed ID: 12455164
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immune globulin.
    Med Lett Drugs Ther; 1992 Dec; 34(886):116-8. PubMed ID: 1465040
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of the immune system in recurrent infection.
    Gaspar HB; Goldblatt D
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):517-20. PubMed ID: 10193456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
    Goldman JM; Schmitz N; Niethammer D; Gratwohl A
    Bone Marrow Transplant; 1998 Jan; 21(1):1-7. PubMed ID: 9486487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brief concept of clinical immunology.
    Ahmed SA
    J Pak Med Assoc; 1975 Jan; 25(1):6-10. PubMed ID: 814267
    [No Abstract]   [Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on the use of intravenous immunoglobulin.
    Dickler HB; Gelfand EW
    Adv Intern Med; 1996; 41():641-80. PubMed ID: 8903601
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical uses of intravenous immunoglobulin in pregnancy.
    Marzusch K
    Am J Obstet Gynecol; 1997 Dec; 177(6):1560-1. PubMed ID: 9423777
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the IVIG mystique.
    Branch DR
    Transfusion; 2013 Feb; 53(2):242-4. PubMed ID: 23384098
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer and immune-mediated disease in people who have had meningococcal disease: record-linkage studies.
    Goldacre MJ; Wotton CJ; Yeates DG
    Epidemiol Infect; 2009 May; 137(5):681-7. PubMed ID: 19046477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product.
    Stiehm ER; Casillas AM; Finkelstein JZ; Gallagher KT; Groncy PM; Kobayashi RH; Oleske JM; Roberts RL; Sandberg ET; Wakim ME
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):848-9. PubMed ID: 9648714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.